Your browser doesn't support javascript.
loading
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study.
Woyach, Jennifer A; Barr, Paul M; Kipps, Thomas J; Barrientos, Jacqueline C; Ahn, Inhye E; Ghia, Paolo; Girardi, Vincent; Hsu, Emily; Jermain, Mandy; Burger, Jan A.
Afiliação
  • Woyach JA; Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
  • Barr PM; Wilmot Cancer Institute, University of Rochester, Rochester, NY 14642, USA.
  • Kipps TJ; University of California San Diego Moores Cancer Center, San Diego, CA 92037, USA.
  • Barrientos JC; Mount Sinai Comprehensive Cancer Center, Miami Beach, FL 33140, USA.
  • Ahn IE; Laboratory of Lymphoid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20814, USA.
  • Ghia P; Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
  • Girardi V; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • Hsu E; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • Jermain M; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • Burger JA; University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cancers (Basel) ; 15(2)2023 Jan 13.
Article em En | MEDLINE | ID: mdl-36672456

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos